130 related articles for article (PubMed ID: 15507108)
1. Neutral endopeptidase and angiotensin-converting enzyme -- key enzymes terminating the action of neuroendocrine mediators.
Scholzen TE; Luger TA
Exp Dermatol; 2004; 13 Suppl 4():22-6. PubMed ID: 15507108
[TBL] [Abstract][Full Text] [Related]
2. Terminating the stress: peripheral peptidolysis of proopiomelanocortin-derived regulatory hormones by the dermal microvascular endothelial cell extracellular peptidases neprilysin and angiotensin-converting enzyme.
Scholzen TE; König S; Fastrich M; Böhm M; Luger TA
Endocrinology; 2007 Jun; 148(6):2793-805. PubMed ID: 17363457
[TBL] [Abstract][Full Text] [Related]
3. Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocorticotropin and alpha-melanocyte-stimulating hormone in the skin.
König S; Luger TA; Scholzen TE
Exp Dermatol; 2006 Oct; 15(10):751-61. PubMed ID: 16984256
[TBL] [Abstract][Full Text] [Related]
4. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.
Skidgel RA; Erdös EG
Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871
[TBL] [Abstract][Full Text] [Related]
6. Expression of neuropeptides and their degrading enzymes in ACD.
Bak H; Lee WJ; Lee YW; Chang SE; Choi JH; Kim MN; Kim BJ; Choi YS; Suh HS
Clin Exp Dermatol; 2010 Apr; 35(3):318-23. PubMed ID: 20030666
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cutaneous inflammation by angiotensin-converting enzyme.
Scholzen TE; Ständer S; Riemann H; Brzoska T; Luger TA
J Immunol; 2003 Apr; 170(7):3866-73. PubMed ID: 12646655
[TBL] [Abstract][Full Text] [Related]
8. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves.
Helske S; Laine M; Kupari M; Lommi J; Turto H; Nurmi L; Tikkanen I; Werkkala K; Lindstedt KA; Kovanen PT
Eur Heart J; 2007 Aug; 28(15):1894-903. PubMed ID: 17507367
[TBL] [Abstract][Full Text] [Related]
10. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.
Moreau ME; Dubreuil P; Molinaro G; Chagnon M; Müller-Esterl W; Lepage Y; Marceau F; Adam A
J Pharmacol Exp Ther; 2005 Dec; 315(3):1065-74. PubMed ID: 16166273
[TBL] [Abstract][Full Text] [Related]
11. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice.
Yamaoka J; Kawana S
J Dermatol Sci; 2007 Nov; 48(2):123-32. PubMed ID: 17692507
[TBL] [Abstract][Full Text] [Related]
12. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis.
Scholzen TE; Steinhoff M; Bonaccorsi P; Klein R; Amadesi S; Geppetti P; Lu B; Gerard NP; Olerud JE; Luger TA; Bunnett NW; Grady EF; Armstrong CA; Ansel JC
J Immunol; 2001 Jan; 166(2):1285-91. PubMed ID: 11145711
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems.
Scholzen T; Armstrong CA; Bunnett NW; Luger TA; Olerud JE; Ansel JC
Exp Dermatol; 1998; 7(2-3):81-96. PubMed ID: 9583747
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation.
Krämer HH; Schmidt K; Leis S; Schmelz M; Sommer C; Birklein F
Exp Neurol; 2005 Sep; 195(1):179-84. PubMed ID: 15963503
[TBL] [Abstract][Full Text] [Related]
15. A comparison of neuropeptide expression in skin with allergic contact dermatitis in human and mouse.
Lim YY; Kim HM; Lee HI; Mun SK; Kim CW; Kim MN; Kim BJ
Int J Dermatol; 2012 Aug; 51(8):939-46. PubMed ID: 22788810
[TBL] [Abstract][Full Text] [Related]
16. Effect of quercetin on plasma extravasation in rat CNS and dura mater by ACE and NEP inhibition.
Cyrino LA; Cardoso RC; Hackl LP; Nicolau M
Phytother Res; 2002 Sep; 16(6):545-9. PubMed ID: 12237812
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase determines the severity of pancreatitis-associated lung injury.
Day AL; Wick E; Jordan TH; Jaffray CE; Bunnett NW; Grady EF; Kirkwood KS
J Surg Res; 2005 Sep; 128(1):21-7. PubMed ID: 15993898
[TBL] [Abstract][Full Text] [Related]
18. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.
Olimpieri F; Tambaro S; Fustero S; Lazzari P; Sanchez-Roselló M; Pani L; Volonterio A; Zanda M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4715-9. PubMed ID: 19596577
[TBL] [Abstract][Full Text] [Related]
20. Immunological localization of neuropeptide-degrading enzymes in the nasal mucosa.
Ohkubo K; Okuda M; Kaliner MA
Rhinology; 1994 Sep; 32(3):130-3. PubMed ID: 7839083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
